Related Experiment Video
Updated: May 3, 2026

05:43
Protocol for Developing a Femur Osteotomy Model in Wistar Albino Rats
Published on: August 31, 2022
2.6K
Supplementary vitamin C does not accelerate bone healing in a rat tibia fracture model
Vincenzo Giordano1, Rodrigo Pires E Albuquerque1, Ney Pecegueiro do Amaral1
1Serviço de Ortopedia e Traumatologia Prof. Nova Monteiro, Hospital Municipal Miguel Couto - Rio de Janeiro, RJ, Brazil.
Acta Ortopedica Brasileira
|January 24, 2014
Summary
This study found that intraperitoneal Vitamin C (ascorbic acid) supplementation did not accelerate bone healing in rat tibia fractures. No significant differences in fracture healing were observed between supplemented and control groups.
Area of Science:
- Orthopedics and Regenerative Medicine
- Biochemistry and Nutrition
Background:
- Ascorbic acid (Vitamin C) is essential for collagen synthesis, a critical component of bone tissue.
- Its role in fracture healing, particularly following supplementation, requires further investigation.
Purpose of the Study:
- To evaluate the effect of intraperitoneal ascorbic acid supplementation on bone healing following experimental tibia fracture in rats.
Main Methods:
- Thirty male Wistar rats underwent tibia fracture and were divided into two groups: one receiving daily intraperitoneal ascorbic acid (200 mg/kg) and a control group receiving saline.
- Fractures were left unstabilized, allowing unprotected weight-bearing.
- Histological and histomorphological analyses of callus tissue were performed at two, four, and six weeks post-fracture.
Main Results:
- No significant histological or histomorphological differences were observed between the ascorbic acid-supplemented group and the control group at any of the time points studied.
- Complete bone union was achieved in all rats in both groups by six weeks post-fracture.
Conclusions:
- Intraperitoneal administration of ascorbic acid does not appear to enhance or accelerate the fracture healing process in this rat tibia fracture model.
- Further research may be needed to explore different dosages, administration routes, or specific fracture types.

